SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 120 filers reported holding SERES THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.20 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $16,000 | -15.8% | 679 | -24.7% | 0.01% | -21.4% |
| Q1 2021 | $19,000 | -13.6% | 902 | +1.5% | 0.01% | -17.6% |
| Q4 2020 | $22,000 | -33.3% | 889 | -24.6% | 0.02% | -37.0% |
| Q3 2020 | $33,000 | +450.0% | 1,179 | -11.6% | 0.03% | +440.0% |
| Q2 2020 | $6,000 | +20.0% | 1,334 | 0.0% | 0.01% | 0.0% |
| Q1 2020 | $5,000 | +25.0% | 1,334 | +4.1% | 0.01% | -37.5% |
| Q4 2019 | $4,000 | -20.0% | 1,281 | +5.2% | 0.01% | -27.3% |
| Q3 2019 | $5,000 | +25.0% | 1,218 | -5.6% | 0.01% | +10.0% |
| Q2 2019 | $4,000 | -20.0% | 1,290 | +84.5% | 0.01% | -58.3% |
| Q1 2019 | $5,000 | – | 699 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 23,117,045 | $110,730,646 | 4.94% |
| Lion Point Capital, LP | 691,803 | $3,313,736 | 1.50% |
| Eversept Partners, LP | 3,076,756 | $14,737,661 | 1.23% |
| Soleus Capital Management, L.P. | 2,045,983 | $9,800,259 | 1.09% |
| Knott David M Jr | 470,000 | $2,251 | 0.90% |
| GREAT POINT PARTNERS LLC | 938,067 | $4,493,341 | 0.88% |
| Simplify Asset Management Inc. | 550,626 | $2,637,499 | 0.35% |
| Delphia (USA) Inc. | 33,913 | $162,443 | 0.26% |
| Alpha DNA Investment Management LLC | 138,536 | $663,587 | 0.22% |
| Avoro Capital Advisors LLC | 2,500,000 | $11,975,000 | 0.16% |